Femasys inc. to participate in upcoming january investor conferences

Atlanta, dec. 23, 2021 (globe newswire) -- femasys inc. (nasdaq: femy), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the company is participating in the lifesci partners 11th annual corporate access event, which will be held virtually from january 5-7, 2022, and the h.c. wainwright bioconnect conference, which will be held virtually from january 10-13, 2022.
FEMY Ratings Summary
FEMY Quant Ranking